News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

San Diego's Palkion Chases Amgen (AMGN)'s Big Market, Joins Race to Develop Oral Anemia Drug


9/1/2009 8:18:53 AM

Xconomy.com -- Amgen’s big break came in the 1980s when it learned how to stimulate the body to make more oxygen-carrying red blood cells. Nobody has topped this achievement for the treatment of anemia in the past 20 years. But now San Diego’s Palkion has joined a list of competitors that hope to capture some billions of their own with a more convenient oral pill that aims to do the same thing as Amgen’s injection.

Read at Xconomy

comments powered by Disqus
Xconomy
Palkion
Amgen
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES